Introduction
There are few available drugs for treatment of fungal infections in immunocompromised patients or in severe systemic pathology. 1 Thus, the search for new compounds with low toxicity and stability is a priority in the field of anti-infectious therapy. Recently SPA-S-843, a new hydrosoluble partricine A polyene derivative, has been synthesized. 2, 3 This polyene possesses unusual stability and high activity against sensitive fungal isolates in comparison with amphotericin B. In this work we investigated the activity of SPA-S-843, compared with that of amphotericin B, against Candida albicans in culture and in contact tests. Furthermore, we investigated the activity of the drug on yeast to mycelium transition of C. albicans, an important step in the pathogenesis of candidosis. 4 
Materials and methods

Antifungal agents
SPA-S-843 (N-dimethylaminoacetyl-partricin A 2-dimethylaminoethylamide diascorbate), potency 941 mg/g (Società Prodotti Antibiotici, Milan, Italy) and amphotericin B, potency 905 mg/g (Squibb, Rome, Italy) were used throughout. The polyenes were dissolved in dimethylsulphoxide (DMSO, Merck, Darmstadt, Germany) at a concentration of 4 g/L and then serially diluted with water to concentrations ranging from 100 mg/L to 0.002 mg/L. In the stability experiments, the polyene solutions (400 mg/L concentration) were protected from light and stored at 22°C.
Microorganisms
Ten clinical isolates and one stock isolate (ATCC 10261) of C. albicans (from the Microbiology Institute's collection) were tested. The isolates were identified by Microscan panels (Baxter, Milan, Italy) and by conventional methods. 5 The cultures were grown in Sabouraud liquid medium overnight at 37°C with shaking, and the growth was estimated with a Thoma Zeiss Camera (Vetro Scientifica S.r.l., Rome, Italy) and controlled by determination of cfu. The final inoculum was 5 10 3 cells/mL in the culture inhibition test, 10 4 cells/mL in the contact tests and 10 6 cells/mL in the K release tests.
Electrical conductivity
The media conductance was measured in S/cm with an HI 9032 conductivity meter (Hanna Instruments, S.p.A., Padova, Italy).
Culture inhibition tests
The experiments were performed in Sabouraud dextrose broth (SAB; Becton-Dickinson, Cockeysville, MD, USA) and diluted Sabouraud dextrose broth (1:3) plus 2% glucose. The inocula (5 10 3 cells/mL) were added to culture media containing serial dilutions of the drugs and to a control 
Contact tests
C. albicans cells were incubated in phosphate buffer, at pH 5.6 and various molarities, in the presence of polyenic drugs for 1-15 min at 22°C. After contact, the cell suspensions were diluted 10 3 times, then seeded in SAB agar. The cfu were determined after 48 h incubation at 37°C, and the results were reported as log cells/mL at that time point.
K release tests
The tests were performed with a K electrode connected to a Microion 2008 (CRISON Instruments S.A., Alella, Barcelona, Spain) with calibration curves adjusted to between 10 -6 mol/L and 5 10 -3 mol/L. The polyene concentrations ranged from 200 to 10 mg/L in sodium phosphate buffer 0.1 M and 0.001 M at pH 5.8. K ions released were measured after 1, 3, 5, 10 and 15 min and were expressed as percentage of K released in the test with respect to the K released from control cell suspensions treated at 100°C for 10 min.
Germ-tube inhibition test
The test was carried out in N-acetylglucosamine solution pH 6.6 with an inoculum of 3 10 5 cells/mL. 6 After 3 h incubation at 37°C the cultures were examined under a light microscope (Carl Zeiss, 320) and the minimum concentration of the polyenes inhibiting 90% of germ-tube formation was microscopically estimated with respect to controls without drugs, where 95% of germ-tube formation usually occurs after 3 h incubation.
Statistical analysis
K (the velocity constant) was used as a measure of the efficiency of antimicrobial agents. K (1/t) log(N i /N f ), where N i is the initial number of cells, N f is the final number of cells and t is the time for the viable count to fall from N i to N f . Differences between mean MIC values were assessed by the Student's t test. Regression analysis was performed using Excel 95.
Results and discussion
SPA-S-843 stock solution protected from light and stored at 22°C was highly stable for at least 10 days, whereas amphotericin B lost most of its activity after 72 h. The antifungal activity of SPA-S-843 in culture media was higher than that of amphotericin B, and was influenced by pH and medium electrical conductivity (Table) .
In the contact experiments SPA-S-843 showed higher cytocidal activity than amphotericin B against C. albicans. The cell kill with SPA-S-843 was 99.99% in 3 min (Figure) . This activity was also affected by pH and electrical conductivity of the phosphate buffer solution used in the experiments. The remarkably rapid cytocidal activity of SPA-S-843 was better displayed in a medium with a low electrical conductivity (0.001 M buffer strength) and with acid pH (pH 5.8), with both factors favouring increase in cell permeability.
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The SPA-S-843 activity was greater than 100 times that of amphotericin B, suggesting a higher candidicidal activity of the former compound. This activity seems to be related to the induction of a greater cellular damage, with accelerated leakage of K ions, as demonstrated by a significant difference between the K leakage induced by SPA-S-843 (80% ion leakage in 4 min) compared with that induced by amphotericin B (35% ion leakage in 4 min).
In the study of yeast to mycelium C. albicans cell transition the SPA-S-843 activity was remarkably higher (mean MIC 0.116 mg/L; range 0.045-0.31 mg/L) than that of amphotericin B (mean MIC 0.45 mg/L; range 0.25-0.62 mg/L). The differences between the mean values were statistically significant (P 0.001).
Because there is evidence that the hyphal form may play a pathogenic role in the initial process of tissue invasion and germ tubes and hyphae adhere better than yeast cells to human buccal and vaginal epithelia, 4 the better inhibition of the morphological transition by SPA-S-843 might improve the effectiveness of the drug.
